Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Vitrolife, a biotechnology and medical device company, has acquired a further 9% of the shares in ATS, the distributor of Vitrolife's products in Italy.
Subscribe to our email newsletter
As a result of this acquisition, Vitrolife owns 60% of the company, with an option to acquire a further 10% within six months.
Magnus Nilsson, CEO of Vitrolife, said: “We are very pleased with how ATS has developed over the past six months: the development of both sales and earnings has been stronger than planned.”